Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Observational Retrospective-prospective Study of Prevalence and Clinical Characteristics of Transthyretin Amyloidosis Cardiomyopathy in Russian Patients With Heart Failure With Preserved Ejection Fraction in Real Clinical Practice

NCT06338839 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06338839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06338839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Observational Retrospective-prospective Study of Prevalence and Clinical Characteristics of Transthyretin Amyloidosis Cardiomyopathy in Russian Patients With Heart Failure With Preserved Ejection Fraction in Real Clinical Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
December 28, 2023
Completion date
June 25, 2024
Enrollment
1,770 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloidosis cardiomyopathy, heart failure with preserved ejection fraction